Business Description
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM
ISIN : MA0000011660
Compare
Compare
Traded in other countries / regions
PRO.Morocco IPO Date
2007-06-15Description
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM is engaged in production, marketing, import and export of pharmaceuticals, parapharmaceuticals, dermopharmaceuticals and cosmetics.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.65 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.15 | |||||
| Interest Coverage | 21.75 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 2.93 | |||||
| Beneish M-Score | 7.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12 | |||||
| 3-Year EBITDA Growth Rate | -7.8 | |||||
| 3-Year Book Growth Rate | 7.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.46 | |||||
| 9-Day RSI | 61.7 | |||||
| 14-Day RSI | 58.86 | |||||
| 6-1 Month Momentum % | -3.82 | |||||
| 12-1 Month Momentum % | -5.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | |||||
| Quick Ratio | 1.04 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 209.58 | |||||
| Days Sales Outstanding | 86.39 | |||||
| Days Payable | 176.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.07 | |||||
| Forward Dividend Yield % | 4.07 | |||||
| 5-Year Yield-on-Cost % | 4.07 | |||||
| Shareholder Yield % | 0.08 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.6 | |||||
| Operating Margin % | 12.53 | |||||
| Net Margin % | 7.06 | |||||
| ROE % | 12.38 | |||||
| ROA % | 6.49 | |||||
| ROIC % | 12.98 | |||||
| ROC (Joel Greenblatt) % | 22.42 | |||||
| ROCE % | 16.32 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| PS Ratio | 1.22 | |||||
| PB Ratio | 2.07 | |||||
| Price-to-Tangible-Book | 2.11 | |||||
| EV-to-EBIT | 8.66 | |||||
| EV-to-EBITDA | 8.66 | |||||
| EV-to-Revenue | 0.99 | |||||
| Price-to-Projected-FCF | 2.59 | |||||
| Price-to-Net-Current-Asset-Value | 6.35 | |||||
| Earnings Yield (Greenblatt) % | 11.55 | |||||
| Forward Rate of Return (Yacktman) % | 0.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MAD) | 805.516 | ||
| EPS (TTM) (MAD) | 0 | ||
| Beta | 0 | ||
| Volatility % | 14.85 | ||
| 14-Day RSI | 58.86 | ||
| 14-Day ATR (MAD) | 11.147139 | ||
| 20-Day SMA (MAD) | 952.2 | ||
| 12-1 Month Momentum % | -5.67 | ||
| 52-Week Range (MAD) | 921 - 1110 | ||
| Shares Outstanding (Mil) | 1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Stock Events
| Event | Date | Price(MAD) | ||
|---|---|---|---|---|
| No Event Data | ||||
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Frequently Asked Questions
What is PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM(CAS:PRO)'s stock price today?
The current price of CAS:PRO is MAD984.00. The 52 week high of CAS:PRO is MAD1110.00 and 52 week low is MAD921.00.
When is next earnings date of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM(CAS:PRO)?
The next earnings date of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM(CAS:PRO) is .
Does PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM(CAS:PRO) pay dividends? If so, how much?
The Dividend Yield %  of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM(CAS:PRO) is 4.07% (As of Today), Highest Dividend Payout Ratio of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM(CAS:PRO) was 2.25. The lowest was 2.25. And the median was 2.25. The  Forward Dividend Yield % of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM(CAS:PRO) is 4.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers